Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren added to losartan in hypertensive type 2 diabetes patients with proteinuria
2004-000895-16Phase 2Terminated
- Sponsor
- Novartis
- Start
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hypertension (HTN), type 2 diabetes mellitus (T2DM) and proteinuria comparing Aliskiren arm with Placebo arm (2 arms). Primary endpoint: Percent change from baseline in urinary albumin/creatinine ratio. Started Aug 2004; status: terminated.
02
Drugs
aliskiren
03
Conditions
hypertension (HTN)type 2 diabetes mellitus (T2DM)proteinuria
Beyond the preview
Go deeper on 2004-000895-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000895-16.